At 20x earnings and 16.7x forward earnings with a PEG of 0.8, the market is pricing FDX as a low-growth cyclical despite clear earnings acceleration to $18.21 next year from $11.4. That multiple compression combined with a Price/Sales of 1 and Price/Book of 3 suggests modest expectations for a company generating a 15.40% operating margin. The Altman Z-Score of 2.8 places it in the gray zone—not distressed, but not fortress-grade either—while a Piotroski F-Score of 8 signals strong internal financial momentum. This looks like a classic GARP setup where improving earnings power is not fully reflected in valuation, but balance sheet quality prevents it from being a pure deep-value bargain.